Trial · NCT03221933
A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA
NCT03221933, Phase 2, Completed, Changchun GeneScience Pharmaceutical Co., Ltd.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA. Trials, record NCT03221933. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03221933
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA
- NCT number
- NCT03221933
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 120 participants, actual
- Lead sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Conditions
- Small for Gestational Age Infant
- Interventions
- Somatropin Injection low dose group, Somatropin Injection high dose group
- First posted
- 2017-07-19
- Last updated
- 2017-12-12
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Height standard deviation score for chronological age (Ht SDSCA) | 26 weeks | HtSDSCA = (height-reference mean for CA) / reference SD for CA (refers to the height value at particular timepoint) |
| Primary | Height standard deviation score for chronological age (Ht SDSCA) | 52 weeks | HtSDSCA = (height-reference mean for CA) / reference SD for CA (refers to the height value at particular timepoint) |
| Primary | Height standard deviation score for chronological age (Ht SDSCA) | 78 weeks | HtSDSCA = (height-reference mean for CA) / reference SD for CA (refers to the height value at particular timepoint) |
| Primary | Height standard deviation score for chronological age (Ht SDSCA) | 104 weeks | HtSDSCA = (height-reference mean for CA) / reference SD for CA (refers to the height value at particular timepoint) |
| Secondary | ΔHtSDSCA | 26 weeks， 52 weeks，78 weeks and 104 weeks | Change in height SDS for chronological age (Ht SDSCA) |
| Secondary | Change in HV | 26 weeks， 52 weeks，78 weeks and 104 weeks | Change in annualized height velocity (HV) |
| Secondary | Change in bone age maturation | 26 weeks， 52 weeks，78 weeks and 104 weeks | |
| Secondary | Change in mole ratio of IGF-1 and IGFBP-3 | 26 weeks， 52 weeks，78 weeks and 104 weeks | |
| Secondary | Change in PAH | 26 weeks， 52 weeks，78 weeks and 104 weeks | Change in prediction of adult height (PAH) |
| Secondary | Change in obesity prevalence | 26 weeks， 52 weeks，78 weeks and 104 weeks |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03221933
GET https://conductscience.org/api/trials/v1/NCT03221933/registered